Glanatec ophthalmic solution 0.4% eye drops (glaucoma Ripasudil, Rho kinase)
What is Glanatec ophthalmic solution for the treatment of glaucoma?
Glanatec ophthalmic solution by Japanese maker Kowa Pharmaceutical is widely used for the supportive treatment of glaucoma and the reduction of eye hypertension (intraocular pressure). This medicine was certified and launched for sale in December 2014 in Japan after full-scale clinical studies. The brand name of the product is Glanatec and the generic name is ripasudil chloride hydrate.
This medicine works by inhibiting Rho kinase, an enzyme affecting proteins that are significant in the contractile control of smooth muscle tissue. As the result, Glanatec eye drops stimulate the movement of aqueous humour from the ciliary body away from the eye and reduce intraocular pressure.
Glanatec is effective for the treatment of progressive glaucoma symptoms, severe cases and patients not responding to other medications. This medicine is safe and generally well-tolerated.
Active principles: ripasudil hydrochloride hydrate
Amount: 5 bottles * 5 ml
Maker: Kowa Pharmaceutical Co., Ltd., Nagoya, Japan
- Increased intraocular pressure,
- Obstructed outflow of fluid from the eye,
- Symptoms associated with glaucoma.
How to use
Adults should apply 1 drop 2 times a day. If you need to use other drops, wait at least five minutes after using Glanatec. Your doctor may adjust the dosage depending on the disease, age and symptoms.
Contraindications: do not use for pregnant or breastfeeding women.
If an allergic reaction occurs, patient needs to stop using the medicine and consult with their doctor. If patient is taking any other medication or treatment, they should consult with their doctor in advance.